1. Market Research
  2. > Pathology
94 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Burkitt Lymphoma Global Clinical Trials Review, H1, 2020

  • $ 2500
  • February 2020
  • 311 pages

Burkitt Lymphoma Global Clinical Trials Review, H##, 2020 H e a l t h c a r e H e a l t h c a r e REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: FEB 2020 LIST OF TABLES LIST OF FIGURES Burkitt Lymphoma Global Clinical Trials Review, H##, 2020 outlines clinical trials in Burkitt

  • Clinical Trial
  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Therapy

Global Cell Expansion Market: Analysis By Product Type, Cell Type, By Application, By Region, By Country : Opportunities and Forecast – By Application, By Region, By Country

  • $ 2400
  • June 2019
  • 284 pages

Lymphoma ##, ## Leukemia ##, ## Myeloma ##, ## Myelodysplastic Syndromes ##, ## Polycythemia Vera ##, ## Thrombocythemia ##, ## Myelofibrosis ##, ## Forms of Blood Cancer Number of Patients Source: LLS Canada FIGURE ##: NUMBER OF BLOOD CANCER CASES IN UNITED STATES, 2018 (c) Azoth Analytics To

  • Healthcare
  • HIV AIDS
  • Insulin Delivery
  • Lymphoma
  • World

Burkitt Lymphoma Global Clinical Trials Review, H2, 2018

  • $ 2500
  • December 2018
  • 303 pages

Burkitt Lymphoma Global Clinical Trials Review, H##, 2018 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: DEC 2018 LIST OF TABLES LIST OF FIGURES Burkitt Lymphoma Global Clinical Trials Review, H##, 2018 outlines clinical trials in Burkitt

  • Clinical Trial
  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody

AIDS - Related Lymphoma Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018
  • 74 pages

AIDS - Related Lymphoma Global Clinical Trials Review, H##, 2018 H e a l t h c a r e H e a l t h c a r e REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: OCT 2018 LIST OF TABLES LIST OF FIGURES AIDS - Related Lymphoma Global Clinical Trials Review, H##, 2018 outlines clinical trials i

  • Chemotherapy
  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018
  • 284 pages

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H##, 2018 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: OCT 2018 LIST OF TABLES LIST OF FIGURES Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H##, 2018 outlines cl

  • Clinical Trial
  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody

Global Invasive Fungal Infection Market - Analysis By Disease Type, Pipeline Drugs, By Region, By Country : Market Insight, Competition and Forecast

  • $ 2200
  • January 2020
  • 225 pages

lymphomas, and multiple myeloma cases in Spain.

  • Antifungal
  • HIV AIDS
  • Infectious Disease
  • Lymphoma
  • Pathology

AIDS - Related Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 24 pages

AIDS - Related Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of AIDS - Related Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing AIDS - Related

  • Cancer
  • Clinical Trial
  • Drug Development
  • HIV AIDS
  • Lymphoma

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal

  • $ 6995
  • December 2019
  • 63 pages

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal Summary Human immunodeficiency virus (HIV) is a chronic disease that can be transmitted through blood, ...

  • Antiviral
  • HIV AIDS
  • Lymphoma
  • Pathology
  • Therapy

The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area

  • $ 500
  • March 2018
  • 55 pages

The Phase III PHOENIX trial, testing the addition of Imbruvica to the current SOC, R- CHOP, in frontline diffuse large B-cell lymphoma (DLBCL) is expected read out in mid- 2018.

  • HIV AIDS
  • Infectious Disease
  • Lymphoma
  • Therapy
  • United States

University of California Los Angeles - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 131 pages

DeGennaro, the Leukemia & Lymphoma Society' s president and CEO.

  • Cancer
  • HIV AIDS
  • Lymphoma
  • Medical Biotechnology
  • Therapy

PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • April 2017
  • 365 pages

PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025 Summary Global HIV therapeutics market was worth approximately US$16.3 billion in 2015, and GlobalData ...

  • Antiviral
  • Hepatitis Treatment
  • HIV AIDS
  • HIV Antiviral
  • Lymphoma

Global Blotting Systems Market 2017-2021

  • $ 2500
  • June 2017
  • 64 pages

Southern blotting Diagnosis of malignant lymphomas, histology, and immunohistochemistry.

  • HIV AIDS
  • Laboratory
  • World
  • Millipore Corporation
  • Thermo Fisher Scientific, Inc.

Kaposi Sarcoma - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 319 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Chemotherapy
  • HIV AIDS
  • Lung Cancer
  • Lymphoma
  • Therapy

Kaposi Sarcoma - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 294 pages

IT IS IN PHASE I STAGE OF DEVELOPMENT FOR DIFFUSE LARGE B CELL LYMPHOMA AND HIGH-GRADE B CELL LYMPHOMA.

  • Chemotherapy
  • HIV AIDS
  • Hospital
  • Lymphoma
  • Therapy

AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2500
  • June 2016
  • 63 pages

AIDS - Related Lymphoma Global Clinical Trials Review, H##, 2016 REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: JUN 2016 LIST OF TABLES AIDS - RELATED LYMPHOMA GLOBAL CLINICAL TRIALS REVIEW, H##, 2016 OUTLINES CLINICAL TRIALS IN AIDS - RELATED LYMPHOMA.

  • HIV AIDS
  • Hospital
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody

EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2025

  • $ 3995
  • January 2017
  • 79 pages

REFERENCE CODE GDHCER##-## | PUBLICATION DATE JANUARY 2017 HUMAN IMMUNODEFICIENCY VIRUS (HIV) - EPIDEMIOLOGY FORECAST TO 2025 Executive Summary Human immunodeficiency virus (HIV) is a lentivirus that impairs and destructs the CD## cells of the immune system (Simon et al., 2006).

  • HIV AIDS
  • Pathology
  • East Asia
  • Japan
  • UNAIDS

Gilead Sciences Inc (GILD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 285 pages

Specific types include large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma (PMBCL), high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma (transformed follicular lymphoma, or TFL).

  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Pharmaceutical
  • Therapy

Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2016

  • $ 1500
  • February 2016
  • 150 pages

CEP-## acts as an anaplastic lymphoma kinase (ALK) inhibitor.

  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • Research And Development
  • United States

Johns Hopkins University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 108 pages

PRODUCT NEWS DEC ##, 2017: THE LEUKEMIA & LYMPHOMA SOCIETY ACHIEVES NEW MILESTONES IN OFFENSIVE AGAINST ACUTE MYELOID LEUKEMIA, DEADLY BLOOD CANCER The Leukemia & Lymphoma Society (LLS) continues its assault against acute myeloid leukemia (AML), a deadly blood cancer that k

  • Cancer
  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • Therapy

Cyclin Dependent Kinase 9 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 117 pages

As a third line therapy for follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia(CLL), diffuse large B-cell lymphoma (DLBCL) and relapsed/ refractory acute m

  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • Research And Development
  • Therapy
View report >

Healthcare Demographic Impact in the US

  • June 2019
  • 50 pages

Jude patients in FY2016-2018 (##. ##%), followed by leukemia (##. ##%), and lymphomas (##. ##%) (Figure ##).

  • Blood Disease
  • Healthcare
  • HIV AIDS
  • Lymphoma
  • United States

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on